Goldstein Advisors LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Goldstein Advisors LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,293 shares of the healthcare conglomerate’s stock after purchasing an additional 37 shares during the quarter. Goldstein Advisors LLC’s holdings in UnitedHealth Group were worth $658,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the business. Macroview Investment Management LLC raised its stake in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. Delos Wealth Advisors LLC raised its position in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares during the last quarter. True Wealth Design LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth $31,000. Bbjs Financial Advisors LLC purchased a new stake in UnitedHealth Group in the second quarter worth $31,000. Finally, Signature Resources Capital Management LLC lifted its stake in UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on UNH shares. HSBC raised their price objective on UnitedHealth Group from $580.00 to $610.00 in a research report on Thursday, July 18th. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Truist Financial raised their price target on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Robert W. Baird raised their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $4.82 during trading hours on Friday, reaching $583.54. 1,107,293 shares of the stock traded hands, compared to its average volume of 4,158,374. The company has a 50 day moving average price of $536.09 and a 200 day moving average price of $509.40. The firm has a market capitalization of $538.85 billion, a price-to-earnings ratio of 35.59, a P/E/G ratio of 1.61 and a beta of 0.59. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $591.54. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the previous year, the firm earned $6.14 EPS. The business’s quarterly revenue was up 6.4% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.44%. UnitedHealth Group’s payout ratio is currently 51.34%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.